First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma

被引：23

作者：

Hainsworth, JD ^{[1
]}

机构：

[1] Sarah Cannon Canc Ctr, Nashville, TN 37203 USA

来源：

SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 01期

关键词：

D O I：

10.1053/sonc.2003.50023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9 / 15

页数：7

共 18 条

[1] HISTOLOGIC CONVERSION IN THE NON-HODGKINS LYMPHOMAS [J].

ACKER, B ;

HOPPE, RT ;

COLBY, TV ;

COX, RS ;

KAPLAN, HS ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (01) :11-16

[2]

Chan WC, 1997, BLOOD, V89, P3909

[3] Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden:: clinical and molecular evaluation [J].

Colombat, P ;

Salles, G ;

Brousse, N ;

Eftekhari, P ;

Soubeyran, P ;

Delwail, V ;

Deconinck, E ;

Haïoun, C ;

Foussard, C ;

Sebban, C ;

Stamatoullas, A ;

Milpied, N ;

Boué, F ;

Taillan, B ;

Lederlin, P ;

Najman, A ;

Thièblemont, C ;

Montestruc, F ;

Mathieu-Boué, A ;

Benzohra, A ;

Solal-Céligny, P .

BLOOD, 2001, 97 (01) :101-106

[4] Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma:: Safety and efficacy of re-treatment [J].

Davis, TA ;

Grillo-López, AJ ;

White, CA ;

McLaughlin, P ;

Czuczman, MS ;

Link, BK ;

Maloney, DG ;

Weaver, RL ;

Rosenberg, J ;

Levy, R .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) :3135-3143

[5] European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma [J].

Foran, JM ;

Rohatiner, AZS ;

Cunningham, D ;

Popescu, RA ;

Solal-Celigny, P ;

Ghielmini, M ;

Coiffier, B ;

Johnson, PWM ;

Gisselbrecht, C ;

Reyes, F ;

Radford, JA ;

Bessell, EM ;

Souleau, B ;

Benzohra, A ;

Lister, TA .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :317-324

[6]

GHIELMINI M, 2002, ANN ONCOL, V13, P18

[7] Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma [J].

Hainsworth, JD ;

Litchy, S ;

Burris, HA ;

Scullin, DC ;

Corso, SW ;

Yardley, DA ;

Morrissey, L ;

Greco, FA .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4261-4267

[8]

Hainsworth JD, 2001, BLOOD, V98, p363A

[9]

Hainsworth JD, 2000, BLOOD, V95, P3052

[10]

HORNING SJ, 1993, SEMIN ONCOL, V20, P75

← 1 2 →